Radian Group Inc. filed a Current Report on Form 8-K on November 5, 2026, reporting that it issued a news release on November 4, 2026, announcing its financial results for the quarter ended September 30, 2026.
Adagio Medical Holdings, Inc. filed a Form 8-K on November 5, 2026, disclosing that it filed a Certificate of Amendment with the State of Delaware on November 4, 2026 to effect a one-for-thirty reverse stock split of its common stock, effective at 5:00 p.m. …
Eagle Bancorp Montana, Inc. filed a Form 8-K on November 5, 2026, disclosing under Item 7.01 (Regulation FD) that its executive officers will present to institutional investors during the first week of November 2026.
Lifetime Brands, Inc. filed a Form 8-K on November 5, 2026, disclosing a Board-authorized increase to its share repurchase program and announcing third-quarter 2026 financial results via press release.
Korsana Biosciences, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting a net loss of $46.4 million for the third quarter and cash and cash equivalents of $456.2 …
Jerash Holdings (US), Inc. filed a Form 8-K on November 5, 2026, disclosing that its board of directors declared a regular quarterly cash dividend of $0.05 per share of common stock, payable on or about November 23, 2026.
Interpace Biosciences, Inc. filed a Form 8-A12B on November 5, 2026, to register its common stock, par value $0.01 per share, for listing on The Nasdaq Stock Market LLC.
Palvella Therapeutics, Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the fiscal quarter ended September 30, 2026.
A Form 4 filed on November 5, 2026 reports that Bryan T. Vaughn, EVP and President, Diagnostics at Labcorp Holdings Inc., sold 306 shares of common stock on November 3, 2026 under a Rule 10b5-1 trading plan.
SCYNEXIS, Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the fiscal quarter ended September 30, 2026, and reporting a net loss of $22.360 million for the nine months ended on that date.